- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01564602
To Compare to 2-channel and Multiple-channel Single Port Laparoscopic-assisted Vaginal Hysterectomy
March 28, 2012 updated by: vghtpe user, Taipei Veterans General Hospital, Taiwan
Prospective Cohort Study to Compare to 2-channel and Multiple Channel Single Port Laparoscopic-assisted Vaginal Hysterectomy
The main objective of this trial is to assess the efficacy and safety of single port-access laparoscopic-assisted vaginal hysterectomy.
The operative time, weight of the uterus, blood loss and hospital stay will be record, respectively.
The pain score is based on the visual analogue scale in which patients record the intensity of their pain 12, 24, and 48 hours after surgery.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Detailed Description
Single port laparoscopy is an attempt to further enhance the cosmetic benefits of minimally invasive surgery while minimizing the potential morbidity associated with multiple incisions.
Preliminary advances in LESS as applied to urologic and gastrointestinal surgery demonstrate that the techniques are feasible provided that both optimal surgical technical expertise with advanced skills and optimal instrumentation are available.
Recently, Lee et al. performed the multiple channel single port-access laparoscopic-assisted vaginal hysterectomy (SPA-LAVH) in 24 patient.
All cases but 3 were performed exclusively through a single port.
The median operative time, weight of the uterus, and estimated blood loss were 119 minutes (range 90 to 255 minutes), 347 g (range 225 to 732 g), and 400 mL (range 100 to 1000 mL), respectively.
The median hospital stay (postoperative day) was 3 days (range 3 to 7).
Although there are a limited number of studies demonstrating the feasibility of single-port access laparoscopic-assisted vaginal hysterectomy (LAVH), single-port surgery is "new-old" (i.e., a revisited and unstandardized technique) because the major disadvantage of limited movement caused by collisions of the laparoscopic instruments has been mitigated by the development of multi-channel approaches.
Therefore, the investigators used a 2-channel single-port system, which was different from the previously published 3-channel single-port technique11,12 to reduce collisions and aid the assistant in controlling the scope without interfering with the surgeon's instruments.
To our knowledge, there are no randomize control trial to evaluate of 2-channel or multiple channel single port laparoscopic surgery in gynecologic disorders.
The purpose of this study was to assess the feasibility of 2-channel and multiple-channel single port laparoscopy in the treatment of benign uterine disease.
Study Type
Interventional
Enrollment (Anticipated)
200
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Taipei, Taiwan, 1121
- Recruiting
- Taipei Veterans General Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- ADULT
- OLDER_ADULT
- CHILD
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Patients receive laparoscopic-assisted vaginal hysterectomy (LAVH)
- American Society of Anesthesiologists (ASA) physical status of patient: classification I-II
Exclusion Criteria:
- The procedure will be required to conversion to laparotomy.
- Any cardio-vascular diseases.
- Malignant disease
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: NA
- Interventional Model: SINGLE_GROUP
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: single port laparoscopic surgery
2-channel or multiple channel single port laparoscopic surgery in gynecologic disorders
|
to compare 2-channel single port and multiple channel port laparoscopic surgery
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The operative time
Time Frame: We will follow the patients until one month after the surgery.
|
We will follow the patients until one month after the surgery.
The primary outcome measure of this trial is the effect and safety of single port-access laparoscopic-assisted vaginal hysterectomy.
|
We will follow the patients until one month after the surgery.
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
weight of the uterus
Time Frame: one month
|
one month
|
|
blood loss
Time Frame: one month
|
one month
|
|
hospital length of stay
Time Frame: one month
|
one month
|
|
morbidity
Time Frame: one month
|
one month
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Study Director: Yi-Jen Chen, PHD, Taipei Veterans General Hospital, Taiwan
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2011
Primary Completion (ANTICIPATED)
January 1, 2014
Study Completion (ANTICIPATED)
December 1, 2014
Study Registration Dates
First Submitted
February 20, 2012
First Submitted That Met QC Criteria
March 27, 2012
First Posted (ESTIMATE)
March 28, 2012
Study Record Updates
Last Update Posted (ESTIMATE)
April 2, 2012
Last Update Submitted That Met QC Criteria
March 28, 2012
Last Verified
March 1, 2012
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- VGH2011-03-011IA
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Myoma
-
Daewon Pharmaceutical Co., Ltd.Completed
-
Tianjin Eye HospitalCompleted
-
University Hospitals Cleveland Medical CenterWithdrawn
-
Ege UniversityCompleted
-
Seoul National University Bundang HospitalCompleted
-
Kangbuk Samsung HospitalCompletedMyomaKorea, Republic of
-
National Cancer Center, KoreaUnknownGynecologic Cancer | Myoma
-
Kafrelsheikh UniversityNot yet recruitingTotal Laparoscopic Hysterectomy With Myoma ScrewEgypt
-
Yonsei UniversityCompleted
-
Aswan University HospitalUnknown
Clinical Trials on comparison multiple channel port laparoscopic surgery
-
Asan Medical CenterUnknownBenign Ovarian or Tubal DiseaseKorea, Republic of
-
Ruijin HospitalRecruiting
-
The Second Hospital of Shandong UniversityRecruitingLung Diseases | SurgeryChina
-
The Second Affiliated Hospital of Chongqing Medical...UnknownLaparoscopic SurgeryChina
-
Fujian Cancer HospitalRecruiting
-
Kyunghee University Medical CenterKyungHee University School of Medicine, KoreaCompletedAppendicitisKorea, Republic of
-
Seoul National University HospitalUnknown
-
Second Affiliated Hospital of Wenzhou Medical UniversityNot yet recruitingOvarian Cysts | Ovarian Diseases | Adnexal Diseases | Uterine Fibroids | Adnexal Mass | Adenopathy | Adnexal CystChina
-
North Tees and Hartlepool NHS Foundation TrustUnknownColorectal Cancer | Inflammatory Bowel Disease | Diverticular Disease | Benign Colorectal NeoplasmUnited Kingdom
-
Sixth Affiliated Hospital, Sun Yat-sen UniversityActive, not recruitingColorectal NeoplasmChina